Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_assertion type Assertion NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_head.
- NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_assertion description "[Recent molecular classification of glioblastoma (GBM) has shown that patients with a mesenchymal (MES) gene expression signature exhibit poor overall survival and treatment resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_provenance.
- NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_assertion evidence source_evidence_literature NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_provenance.
- NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_assertion SIO_000772 22190458 NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_provenance.
- NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_assertion wasDerivedFrom befree-2016 NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_provenance.
- NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_assertion wasGeneratedBy ECO_0000203 NP948594.RAco676Xj1FealaTK3eK_mO5IfmgAPRC9MqagwZuUK6ac130_provenance.